STAT+: What to expect from the Moderna-Merck cancer vaccine data reveal
The Moderna-Merck cancer vaccine data reveal is days away. Here's what to expect.
Recent health headlines from STAT News.

Moderna and Merck's 'presidential' presentation, and other news from Day 2 of the European Society for Medical Oncology meeting in Madrid.

The Moderna-Merck cancer vaccine data reveal is days away. Here's what to expect.

U.S. is poised to issue a proposed rule that would subject outbound licensing deals with Chinese biotech companies to…

A KFF survey finds that rising healthcare costs are squeezing both employers and workers.

GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous…

An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye…

The median net price for newly launched medicines, when adjusted for inflation and manufacturer discounts, rose by 35%…

A jury awarded $6 million in damages to scientist David Sabatini, whose career imploded after he was accused by a much…

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical…

Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry.

White House planned shift of research funding from universities to industry risks creating a drought in basic…

A wave of clinical trials have begun to test the ability of GLP-1 weight loss drugs to quell various substance use…

Humana is swapping out private equity sponsors for its CenterWell Senior Primary Care clinics. Good bye, Welsh,…

Patient advocates and some experts are expressing growing alarm over the perceived risks of a Neurocrine Biosciences…

“Hordes of brilliant, graduate-degree-holding professionals in their 40s, 50s, and beyond act helpless at work,”…

Patient advocates and some experts are expressing growing alarm over the perceived risks of a rare disease drug sold…

“The legal and medical issues in the Christa Pike case are on a collision course,” writes bioethicist M. Sara Rosenthal.

Health As CDC redesigns annual health survey, it removes questions about disabilities The changes could result in…

Why have so many Americans lost trust in science? And what's the deal with a new gene-editing lawsuit? Find out on…

Health care companies dominate the MAHA Summit, and a look at Trump's watered down effort to lower Medicare drug prices.

In the Lab Judge blocks Trump administration plans to limit visa length for grad students, postdocs Proposed 4-year…

11, 2026 Pharmalot Columnist, Senior Writer Ed Silverman[email protected]Ed’s stories explore prescription drug…

Platinum chemotherapy's long-term effects, surprising heart failure drug failures, and more biotech news from The…

Naloxone and harm reduction measures may be helping to curb drug overdose deaths, a new report says.

28, 2026 Europe Correspondent Andrew Joseph[email protected]Andrew covers the biopharma industry, scientific research,…

“Once medical aid in dying becomes available, the status quo changes,” writes Monika Piotrowska.

OpinionFirst Opinion Many post-Dobbs abortion fears have not come to pass. Arguments about abortion rights should be…

Women's health experts suggest a 'reverse pitch' approach to endometriosis, osteoporosis, and autoimmune treatments,…

STAT PlusPharma New treatments for common cardiovascular risk factor near the market, with billions at stake Unlike…

FTC challenges Amgen's Enbrel patent strategy, the long, winding path for the Moderna-Merck cancer vaccine, and more…

24, 2026 Business of Health Care Reporter Bob Herman[email protected]Bob covers the money in health care, focusing on…

24, 2026 Reporter, Commercial Determinants of Health Sarah Todd[email protected]Sarah covers how industries like food…

Merck and Moderna's mRNA cancer vaccine, an expected nominee to lead the FDA, and more biotech news from The Readout

Dear Readers, When we launched STAT more than a decade ago, our mission statement promised that we would deliver…

The suit, brought by a nonprofit that advocates for plant-based diets, claims HHS and the USDA used a “secret panel”…

Municipalities are struggling with the cost of health insurance for their workers, and states are facing a major…

Eyepoint disclosed that a Phase 3 trial of its experimental treatment for a common cause of age-related blindness fell…

Zoom in closely enough, and instead of streets and buildings, there are proteins and strands of RNA and DNA. Then…

Doritos as "real" "food," public-sector health care in trouble, and more health news from Morning Rounds

Politicians are contemplating raising taxes and cutting benefits as the cost of health care for government workers…

“Everything about the West case shows how miserably surrogacy has been managed in America,” writes Arthur Caplan.

“Like climate change, antimicrobial resistance is a global challenge, but its causes and consequences are unevenly…

Doritos in the classic nacho cheese flavor have 27 ingredients, including not just familiar ones but also a number of…

Eyepoint said patients given its experimental treatment for wet AMD failed to maintain vision with less frequent…

UnitedHealth faces an investigation over tax payments, and we examine why PE deals for doctor groups are slowing.

17, 2026 Morning Rounds Writer and Reporter Theresa Gaffney[email protected]Theresa is the lead Morning Rounds writer,…

“A growing body of evidence shows that fathers make unique, independent contributions to children's health and…

OpinionFirst Opinion We proved bipartisan health care reform works in North Carolina. Let’s bring it nationwide Our…

Mike Reddy for STAT STAT PlusSpecial Report Epic confronts unprecedented challenges as it prepares to address…

The health insurer may face a significant increase in taxes, amid a dispute with federal authorities.
WeSearch's declared handling of STAT News's content. Indexing, snippets, summaries, retrieval and training are separate questions — see the rights registry or read this source's machine-readable record.